Bloom Science, Inc.
Industry
- Pharmaceuticals
- Biotechnology
See more in Biomedtracker
Latest on Bloom Science, Inc.
Scrip
• By Ayisha Sharma
Bloom Science, Inc. is advancing a pipeline of live biotherapeutics derived from gut commensal microbes to alter key brain-gut microbiome interactions in a bid to treat rare neurological disorders. T
Scrip
• By Mandy Jackson
[Sidebar#SC145549] Biopharmaceutical companies and other life science start-ups may access $1.28bn in new venture capital available through four different sources, including Eir Venture Partners AB’s